Davenport & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
4,719
-91,886
| -95% | -$22.2M | 0.01% | 641 |
|
|
2025
Q1 | $23.5M | Buy |
96,605
+11,928
| +14% | +$2.91M | 0.14% | 141 |
|
|
2024
Q4 | $27.8M | Buy |
84,677
+27,780
| +49% | +$9.13M | 0.16% | 128 |
|
|
2024
Q3 | $19M | Buy |
56,897
+590
| +1% | +$197K | 0.11% | 155 |
|
|
2024
Q2 | $15.4M | Buy |
56,307
+11,954
| +27% | +$3.26M | 0.09% | 164 |
|
|
2024
Q1 | $15.3M | Buy |
+44,353
| New | +$15.3M | 0.09% | 168 |
|
|
2022
Q1 | – | Sell |
-288
| Closed | -$218K | – | 1043 |
|
|
2021
Q4 | $218K | Hold |
288
| – | – | ﹤0.01% | 979 |
|
|
2021
Q3 | $215K | Buy |
+288
| New | +$215K | ﹤0.01% | 956 |
|